Pork producers' views on the sulfamethazine issue.

Area of Science:

• Veterinary Pharmacology
• Food Safety
• Animal Husbandry

Background:

• Sulfamethazine residues in pork are a concern for Food and Drug Administration (FDA) compliance.
• Violations stem from inadequate drug withdrawal periods and accidental feed/environmental contamination.
• Cull animals are frequently implicated in residue violations.

Purpose of the Study:

• To address the issue of sulfamethazine residue violations in slaughtered pigs.
• To support industry efforts in maintaining pork safety and consumer confidence.
• To evaluate current strategies and proposals for residue reduction.

Main Methods:

• Analysis of current sulfamethazine residue levels in slaughtered pigs.
• Review of contributing factors to violations, including drug withdrawal practices and contamination.
• Examination of industry and regulatory responses, including NPPC initiatives and FDA evaluations.

Main Results:

• Currently, less than 0.4% of slaughtered pigs exhibit sulfamethazine levels exceeding FDA allowances.
• Primary causes identified are improper drug withdrawal and inadvertent contamination.
• The National Pork Producers Council (NPPC) actively supports residue reduction efforts.

Conclusions:

• The NPPC advocates for suspending sulfamethazine use and developing improved testing and traceback systems.
• The NPPC opposes the proposed "bill back" system due to concerns about testing accuracy and market disruption.
• Continued evaluation by the FDA and industry collaboration are crucial for managing sulfamethazine residues.